{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial Comparing Supra-Annular and Intra-Annular Aortic Valve Replacement"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Due to the retrospective nature, randomisation and blinding were not applicable."
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at Kartal Kosuyolu High Specialization Training and Research Hospital, this retrospective observational study included 113 patients over 18 years who underwent isolated AVR between March 2013 and June 2019."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were divided into supra-annular (n=59) and intra-annular (n=54) groups."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the early outcomes of supra-annular versus intra-annular aortic valve replacement (AVR) in patients undergoing isolated AVR."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the difference in postoperative complications and echocardiographic findings at one month."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Due to the retrospective nature, randomisation and blinding were not applicable."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Due to the retrospective nature, randomisation and blinding were not applicable."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Patients were divided into supra-annular (n=59) and intra-annular (n=54) groups."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The supra-annular group had significantly longer cross-clamp (74.44\u00b115.71 min) and cardiopulmonary bypass times (106.98\u00b122.06 min) compared to the intra-annular group (48.31\u00b113.21 min and 76.63\u00b123.41 min, respectively; p<0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were comparable, with no significant differences in early mortality rates."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "No trial registration or funding information was provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "No trial registration or funding information was provided."
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}